The use of L-asparaginase in the treatment of ALL can be traced back to the early studies of Broom et al. who found that the anti-leukemic effect of L-asparaginase is attributed to its ability to hydrolyze L-asparagine, which is required for tumor cell survival [8]. This evidence concerns the gene ASPG and neoplasm.